Literature DB >> 19231067

Identificating 14-3-3 sigma as a lymph node metastasis-related protein in human lung squamous carcinoma.

Dan-Juan Li1, Gui Deng, Zhi-Qiang Xiao, Hui-Xin Yao, Cui Li, Fang Peng, Mao-Yu Li, Peng-Fei Zhang, Yong-Heng Chen, Zhu-Chu Chen.   

Abstract

In this study, we aim to screen metastasis-related proteins in human lung squamous carcinoma (LSC) using laser capture microdissection and a proteomic approach. Twenty two differential proteins were identified from pooled microdissected primary LSC and matched lymph node (LN) metastatic tissues. Expression of the differential protein 14-3-3 sigma was determined by Western blotting and immunohistochemistry. In cell invasion assay, down-regulated 14-3-3 sigma by siRNA increased in vitro invasive ability of HTB-182 and A549 cells, up-regulation of 14-3-3 sigma by pcDNA3.0/14-3-3 sigma decreased in vitro invasive ability of HTB-182 and A549 cells. The data suggest that 14-3-3 sigma is a potential LN metastasis-related protein in LSC, and its dysregulation might play an important role in the LN metastatic process of LSC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19231067     DOI: 10.1016/j.canlet.2009.01.028

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Three-gene molecular diagnostic model for thyroid cancer.

Authors:  Nijaguna B Prasad; Jeanne Kowalski; Hua-Ling Tsai; Kristin Talbot; Helina Somervell; Guennadi Kouniavsky; Yongchun Wang; Alan P B Dackiw; William H Westra; Douglas P Clark; Steven K Libutti; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

Review 2.  The grand challenge to decipher the cancer proteome.

Authors:  Samir Hanash; Ayumu Taguchi
Journal:  Nat Rev Cancer       Date:  2010-09       Impact factor: 60.716

Review 3.  Proteomic research progress in lymphatic metastases of cancers.

Authors:  Junwei Zong; Chunmei Guo; Shuqing Liu; Ming-Zhong Sun; Jianwu Tang
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

Review 4.  Unravelling the complexity of metastasis - molecular understanding and targeted therapies.

Authors:  Nilay Sethi; Yibin Kang
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 5.  14-3-3 proteins as potential therapeutic targets.

Authors:  Jing Zhao; Cheryl L Meyerkord; Yuhong Du; Fadlo R Khuri; Haian Fu
Journal:  Semin Cell Dev Biol       Date:  2011-10-01       Impact factor: 7.727

6.  14-3-3ζ Overexpression and abnormal β-catenin expression are associated with poor differentiation and progression in stage I non-small cell lung cancer.

Authors:  Dongyu Zang; Xiaoming Li; Lin Zhang
Journal:  Clin Exp Med       Date:  2010-01-29       Impact factor: 3.984

7.  Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics.

Authors:  Gu-Qing Zeng; Pang-Fei Zhang; Xingming Deng; Feng-Lei Yu; Cui Li; Yan Xu; Hong Yi; Mao-Yu Li; Rong Hu; Jian-Hong Zuo; Xin-Hui Li; Xun-Xun Wan; Jia-Quan Qu; Qiu-Yan He; Jian-Huang Li; Xu Ye; Yu Chen; Jiao-Yang Li; Zhi-Qiang Xiao
Journal:  Mol Cell Proteomics       Date:  2012-01-31       Impact factor: 5.911

8.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

9.  Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.

Authors:  Chun-I Wang; Kun-Yi Chien; Chih-Liang Wang; Hao-Ping Liu; Chia-Chen Cheng; Yu-Sun Chang; Jau-Song Yu; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2012-07-25       Impact factor: 5.911

Review 10.  Proteomic biomarkers in lung cancer.

Authors:  M D Pastor; A Nogal; S Molina-Pinelo; A Carnero; L Paz-Ares
Journal:  Clin Transl Oncol       Date:  2013-04-20       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.